Market News & Trends
ZIOPHARM & Intrexon Announce Worldwide Partnership for Synthetic Biology DNA-Based Oncology Therapeutics
ZIOPHARM Oncology, Inc., a small molecule late-stage oncology drug development company, and Intrexon Corporation, a next-generation synthetic biology company, recently announced a global exclusive channel…
1/18/2011
Amgen & Xencor to Co-Develop Novel Antibody; Deal Worth $500 Million Xencor, Inc. and Amgen recently announced they will collaborate to develop XmAb5871, an Fc-engineered monoclonal…
3M DDS Signs Licensing Agreement With Spirig Pharma AG
3M Drug Delivery Systems recently announced it has signed an exclusive licensing agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products.…
Elan Pays Transition Therapeutics $9 Million in Amended Deal for Phase II Candidate
Transition Therapeutics Inc. recently announced the company and Elan Corporation, plc have mutually agreed to modify their collaboration agreement for the development and commercialization of…
Itamar Medical & Roche Sign Agreement For EndoPAT Devices in Preclinical Drug Development
Itamar Medical, a leader in non-invasive vascular health diagnostics, recently announced that an agreement has been signed with Roche by which Itamar will develop an…
Ligand Pharmaceuticals Earns $1 Million Up-Front Payment From Pfizer
Ligand Pharmaceuticals Incorporated recently announced its partner Pfizer, Inc. has granted a sublicense to a multinational pharmaceutical company for Tanaproget, also known as NSP-989. As…
Novo Nordisk & Emisphere Announce License Agreement to Develop Oral Formulation of Insulin for $57.5 Million
Emisphere Technologies, Inc. and Novo Nordisk A/S recently announced they have entered into an exclusive development and license agreement to develop and commercialize oral formulations…
Omeros Corporation Announces Positive Phase I/II Clinical Results of OMS201
Omeros Corporation, a biopharmaceutical company committed to discovering, developing, and commercializing products focused on inflammation and disorders of the central nervous system, recently announced results…
*Latest Events
Pre-Filled East Coast 2018 April 10-12 Boston, MA Pre Filled Syringes East Coast April 11 - 12 Boston, MA INTERPHEX April 17-19 New York City…
